Today's Healthcare Pulse
Pharma Shifts Ad Spend to Spot TV Amid Heightened FDA Scrutiny
Pharmaceutical advertisers are redirecting dollars toward spot television placements as the FDA intensifies its oversight of drug marketing. The trend reflects a strategic move to capture audiences with shorter, targeted ads while navigating tighter regulatory expectations.
Also developing:
By the numbers: Apogee Therapeutics secures $1.3B royalty financing
Regulatory and Scientific Frontiers in Drug Repurposing: Accelerating Therapeutic Innovations for Unmet Medical Needs + Examples of Repurposed Drugs
On May 11, 2026 the FDA unveiled a formal drug‑repurposing program aimed at accelerating clinical trials for approved compounds targeting chronic, rare and underserved conditions. The initiative builds on prior legislation such as the Best Pharmaceuticals for Children Act and the MODERN Labeling Act, and opens a public docket for stakeholder submissions through June 11. By leveraging real‑world evidence, AI‑driven analytics and the 505(b)(2) pathway, the program seeks to shorten development timelines to 3‑12 years and reduce costs to roughly $300 million. Early examples like sildenafil and the newly approved sotatercept illustrate how repurposing can generate multi‑indication revenue streams and address high‑unmet‑need diseases.
Pancreatic Cancer Halted by Virus Injection in Three Patients
In a U.S. Phase 1 safety trial, an engineered oncolytic virus halted tumor growth and prevented spread in three pancreatic cancer patients. Researchers administered only one‑tenth of the intended therapeutic dose, yet observed clear disease control. Lead developer Masato Yamamoto highlighted...
Where Medical Expertise Meets Advanced Skin Care: Manila Doctors Hospital Now Offers Skin and Laser Services
Manila Doctors Hospital (MDH) has opened a hospital‑based Skin and Laser Center within its Aesthetics Center, delivering medical‑grade dermatology and laser procedures under clinical supervision. Led by chief dermatologist Dr. Cindy Jao Tan and a team of board‑certified specialists, the...
Why Africa – and the World – Remain Dangerously Unprepared for the Next Pandemic
The WHO’s Global Preparedness Monitoring Board released its 2026 "A World on the Edge" report amid a fresh Ebola outbreak in the Democratic Republic of Congo, which the WHO declared a public health emergency of international concern. The report finds...
Development of a Clinical Prediction Model for Parenteral Nutrition-Associated Cholestasis in Preterm Infants: A Retrospective Cohort Study
A retrospective cohort of 329 preterm infants identified three independent predictors of parenteral nutrition‑associated cholestasis (PNAC): birth weight ≤1,375 g, hemodynamically significant patent ductus arteriosus, and maximum daily parenteral amino‑acid intake ≥4.01 g/kg/day. The multivariable model achieved an area under the ROC...
Effect of Percutaneous Acupoint Electrical Stimulation Combined with Nutritional Support on Gastrointestinal Function and Nutritional Status of Patients After Unicondylar...
A randomized controlled trial of 60 unicondylar knee arthroplasty patients found that adding percutaneous acupoint electrical stimulation to standard postoperative care and conventional nutritional support markedly accelerated gastrointestinal recovery and improved nutritional biomarkers. The experimental group achieved an 86.7% overall...
‘It’s Not Super Useful’: As Wariness About AI Grows, Trump Proposes Rollback of Healthcare Safeguards
The Trump administration is proposing to roll back federal safeguards that require user‑centered testing and transparency for AI‑driven healthcare tools, including electronic health record (EHR) scribe software. Clinicians like Kaiser Permanente therapist Paul Boyer find current AI scribes, such as...
How APAC Should Deploy AI to Find Hidden Lung Cancers
AI is moving from pilot projects to routine use in several APAC markets, including Malaysia, Indonesia, Vietnam and the Philippines, as health systems grapple with limited CT capacity and radiology shortages. Qure.ai’s chief medical officer highlights that one‑third of lung‑cancer...
![[Comment] Advancing Tau-PET Imaging in Alzheimer's Disease](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/d7dfbf5e1c7160c8f2aa1fa113274d6e.webp)
[Comment] Advancing Tau-PET Imaging in Alzheimer's Disease
The Lancet commentary highlights how tau‑PET imaging has moved from a research novelty to a cornerstone of Alzheimer’s disease diagnosis and drug development. Over the past decade, radioligands such as [18F]flortaucipir have become essential inclusion criteria and outcome measures in...
![[Comment] Offline: The Dishonest Politics of Global Health](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/43c18925e9387aaa45d34e13dcfde489.webp)
[Comment] Offline: The Dishonest Politics of Global Health
The World Health Assembly was dominated by the fresh Ebola outbreak in the Democratic Republic of Congo, where a 23‑day gap between case detection and the WHO’s Public Health Emergency declaration highlighted chronic surveillance failures. Delegates also debated a new...
![[Comment] Prasinezumab: What Have We Learned From PASADENA and PADOVA?](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/f31e0b4ec0510b45a35ec13b633c65e2.webp)
[Comment] Prasinezumab: What Have We Learned From PASADENA and PADOVA?
Prasinezumab, an antibody targeting aggregated α‑synuclein, was tested in the phase‑2 PASADENA trial in early‑stage Parkinson's patients. The study failed to meet its primary endpoint—change in the combined MDS‑UPDRS I‑III score after 52 weeks—though the low‑dose arm showed modest improvement...
![[Comment] Multi-Arm Multi-Stage Platform Trials for Neurological Disease: Accelerating Progress](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/c5e0887cefc9d7a6210ea0a37fc55823.webp)
[Comment] Multi-Arm Multi-Stage Platform Trials for Neurological Disease: Accelerating Progress
The Lancet commentary highlights multi‑arm multi‑stage (MAMS) platform trials as a solution to the sluggish pace of neurodegenerative drug development. By testing several mechanistically‑selected candidates within a single adaptive protocol, researchers can reach definitive phase‑3 conclusions faster. The piece cites...
Ukraine Scales VR Therapy to Aid 1,100 War‑Trauma Patients
Ukraine has finished a six‑month, large‑scale deployment of mixed‑reality therapy across 47 health facilities, delivering 8,884 sessions to 1,114 patients. The program, run by health‑tech startup Aspichi and funded by Germany’s GIZ, aims to relieve a mental‑health system strained by...
ASU Researchers Unveil Urine Test Detecting Autism Risk with 90% Sensitivity
Arizona State University scientists have created a urine‑based screening tool that distinguishes children with autism from typically developing peers with 90% sensitivity and 100% specificity. The test, called the Microbially‑Derived Metabolite (MDM) System, could give parents and clinicians a faster...
Preventing Stunting — Lessons From a Western Cape Maternal Health Pilot
Rising food insecurity has left 17.5% of Western Cape children under five stunted, threatening cognitive development and long‑term health. In response, the Western Cape Government, DG Murray Trust, Shoprite and Grow Great launched the Khulisa Care pilot, a cash‑plus‑care model...
Ocrelizumab Cuts Disability Progression 30% in PPMS
In primary progressive MS, ocrelizumab was associated with a 30% lower risk of disability progression than placebo in a broad Phase III trial. Benefits were also seen in patients with advanced disease, though one subgroup stood out more. multiplesclerosis
CMS Finalizes Rule to Simplify Payer-Provider Disputes Under No Surprises Act
The Centers for Medicare & Medicaid Services (CMS) finalized a rule on Thursday to overhaul the independent dispute resolution (IDR) process created by the No Surprises Act. The rule slashes the administrative fee from $115 to $15 per party and...
Ōura to Add Blood Pressure Feature Following FDA Policy Change
Ōura introduced the Ring 5 smart ring and announced a suite of new health features to roll out in June. The updates include nighttime blood‑pressure trend monitoring, which reports pressure patterns without systolic/diastolic numbers, and a 30‑day view of breathing regularity....
US Healthcare Still Stupidly Expensive, with Pathetic Outcomes, Study Finds
The Commonwealth Fund’s 2024 analysis of 20 health systems finds the United States a persistent failure, spending far more while delivering poorer outcomes. The U.S. devoted 18% of its GDP to health care—nearly twice the 9.3% average of peer nations—and...
Historical Information on REMS for Opioid Analgesics
The U.S. Food and Drug Administration has built a class‑wide Risk Evaluation and Mitigation Strategy (REMS) for opioid analgesics through a series of actions spanning 2010‑2017. Early advisory committee meetings in 2010 set the groundwork, leading to mandatory safety measures...
Siemens Healthineers, AiM Team up; Procept Completes Study Enrollment
Siemens Healthineers and AiM Medical Robotics announced a collaboration to integrate AiM’s portable robotic neurosurgery platform with Siemens’ Magnetom MRI scanners, enabling MRI‑guided procedures such as deep‑brain stimulation and tumor ablation. AiM, which raised $8.1 million in a Series A round last...
BREAKING: Study Finds Pediatric Flu Shots Are a COMPLETE FAILURE
A peer‑reviewed study of a Spanish health region covering about 400,000 residents found that expanding flu vaccination to children aged six months to five years did not produce a statistically significant decline in influenza diagnoses or related hospitalizations. Researchers analyzed...
How Framework Modernization Benefits Public Health Data Exchange
Eric Larson, senior health‑IT lead at AIRA, highlighted how adopting the FHIR standard for immunization registries streamlines data queries for clinicians and gives patients direct, mobile access to their vaccination records. The move replaces fragmented legacy interfaces with a unified...
Experts Convened by WHO Advise on Candidate Treatments and Vaccines for Ebola Disease Caused by Bundibugyo Virus
The World Health Organization (WHO) convened its R&D Blueprint and SAGE advisory groups to evaluate candidate vaccines and therapeutics for the Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo and Uganda. Experts recommended that all identified...
This Biotech Is Leading What Could Be a 'GLP-1 Moment for Hair Loss,' Says BTIG
Absci Corporation’s AI‑designed antibody ABS‑201 is entering Phase 1/2A trials for androgenetic alopecia, a market of roughly 80 million Americans. BTIG upgraded coverage to a buy with a $9 price target, forecasting up to $2.2 billion in peak sales and likening the drug...
HCA Texas Hospital Taps COO
HCA Houston Healthcare Northwest announced the appointment of Angela Dillon as chief operating officer, effective May 18. Dillon joins from Sunrise Hospital & Children’s in Las Vegas, where she was vice president of operations and co‑ethics compliance officer. She previously served as associate...
Brief: Can Medicare Help More Patients Stay on Home Dialysis?
Rep. Carol Miller introduced the Improving Home Dialysis Act (H.R.8875), which would add two Medicare‑covered support services—staff‑assisted home‑dialysis respite care and up to four renal mental‑health sessions—for patients starting home dialysis. A budget‑neutrality waiver means the new payments would be...
Immunization Reporting Gets a Shot in the Arm From Interop Efforts
Eric Larson, senior health‑IT lead at the American Immunization Registry Association, says new interoperability initiatives are streamlining the flow of vaccination data among electronic health records, pharmacies and state registries. By leveraging standardized APIs and FHIR resources, clinicians can now...
Novant Health Buys South Carolina Land to Build $25M Medical Hub
Novant Health, headquartered in Winston‑Salem, N.C., completed a $4.34 million purchase of a former automotive site in Hilton Head, S.C., to build a $25.3 million, 25,000‑square‑foot medical hub. The campus will host primary care, physical therapy and urology services, adding 15,000 sq ft of...
Non‑CD20 MS Drugs Cause Irreversible Damage, CD20 Better
Just re-upping this important $TGTX thread from a while ago - bottom line here, MS patients on the weaker (non-CD20) drugs like teriflunomide (Aubagio) suffer ongoing, irrecoverable damage. There are some larger ongoing trials comparing CD20 drugs to others that...
AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood Cancer
AbbVie secured FDA approval for Decnupaz (pivekimab sunirine), an antibody‑drug conjugate that targets CD123 in blastic plasmacytoid dendritic cell neoplasm (BPDCN), an ultra‑rare aggressive blood cancer. In a Phase 1/2 trial, 69.7% of treatment‑naïve patients achieved complete or clinical remission, while...
Vaccine Shows Promise Against Aggressive Brain Cancer
A phase‑1 trial of Geneos Therapeutics' DNA‑based vaccine GNOS‑PV01 at Washington University’s Siteman Cancer Center demonstrated safety and a survival advantage in patients with aggressive glioblastoma. The personalized vaccine, which encodes up to 40 tumor‑specific neoantigens, showed no serious adverse...
6 Healthcare Leaders Named to Fortune’s Most Powerful Women List
Fortune’s 2026 Most Powerful Women list highlighted six senior women in healthcare, including two health‑insurance CEOs. The rankings, released May 27, span 100 leaders across 94 companies worldwide and assess size, innovation, influence, trajectory and impact. Vertex Pharmaceuticals’ Reshma Kewalramani...
News Briefs: CMS Proposes a Modest Increase to Hospital Inpatient Payments for FY27
The Centers for Medicare & Medicaid Services (CMS) has proposed a 2.4% increase in the average Medicare inpatient payment for FY27, translating to roughly $1.4 billion industry‑wide. After accounting for quality‑data, EHR‑use adjustments and a mandatory productivity cut, the net rise...
Antiseptic Meetings
The Over-the-Counter Monograph Safety, Innovation, and Reform Act was signed into law on March 27, 2020, aiming to modernize FDA regulation of OTC monograph drugs. Since then, the FDA has held a series of technical meetings with industry groups such...
Untreated MASH With T2D to Drive Costs 5-Fold: Zobair Younossi, MD
Metabolic dysfunction‑associated steatohepatitis (MASH) combined with type 2 diabetes is projected to cost the U.S. health system nearly five times more by 2040 if current practices persist. Although FDA‑approved therapies exist, primary‑care and endocrinology settings still stratify very few patients, leaving...
When Nurses Shape the Technology, Patients Feel the Difference
University Health Kansas City, led by chief nursing officer Amy McTaggart, partnered with Philips to replace fragmented digital tools with a centralized monitoring hub. The integration cut non‑actionable alarms by 22% and reduced waveform‑strip documentation time by 69.6%, saving more...
Teladoc Adds Virtual Care Services to Walmart Digital Health Platform
Teladoc Health announced a partnership with Walmart to embed its virtual care services—urgent care, dermatology and nutrition support—into Walmart’s Better Care Services platform. The integration lets consumers access 24/7 urgent care for a cash price of $89 per visit, alongside...
AI Presses Nursing Education to Evolve, but Which Way Will It Go?
A new report from nursing science leaders calls for standardized AI education, ethical safeguards, and rigorous evaluation frameworks to ensure AI tools enhance, not hinder, patient care. It emphasizes that nurses must understand AI mechanics, bias, and workflow impacts, and...
FDA Approves Durvalumab in Combination with Bacillus Calmette-Guerin for High-Risk Non-Muscle Invasive Bladder Cancer
The FDA approved durvalumab (Imfinzi) in combination with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The decision follows the POTOMAC trial, which enrolled 1,018 patients and demonstrated a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015)....
Bring on the Breakthroughs: ASCO Takes Translation to More Patients
The 2026 American Society of Clinical Oncology (ASCO) meeting in Chicago spotlights the theme “The Science and Practice of Translation,” showcasing data that move laboratory breakthroughs into everyday cancer care. Highlighted trials include PROTEUS, a phase‑3 study adding apalutimide to...
FDA Grants Coredio Breakthrough Designation for AI Platform Bringing Advanced Heart Failure Assessment Beyond the Hospital
Coredio’s Cardiac Performance Simulation Engine (CPSE™) received FDA Breakthrough Device Designation and entry into the Total Product Life Cycle Advisory Program, accelerating its path to a 510(k) clearance. The SaMD platform translates data from consumer smartwatches and standard blood‑pressure cuffs...
Blackstone Commits up to $1.3 Billion to Fund Apogee Therapeutics' Zumilokibart Program
Blackstone Life Sciences announced a financing package of up to $1.3 billion for Apogee Therapeutics, combining $800 million in synthetic royalty financing and $500 million in senior debt. The capital will accelerate development and potential commercialization of Apogee’s lead monoclonal antibody, Zumilokibart, targeting...
Coleman and Tepper Slash UnitedHealth Stakes, Sparking Health‑Care Re‑Assessment
Chase Coleman’s Tiger Global Management and David Tepper’s Appaloosa Management sold large portions of their UnitedHealth Group holdings in the first quarter of 2026—17% and 55% respectively. The moves, made ahead of UnitedHealth’s earnings release, have ignited speculation that top...
GSK’s Hepatitis B Drug Shows Functional Cure in 1 in 5 Patients
GSK and Ionis reported that bepirovirsen produced a functional cure in roughly one‑in‑five chronic hepatitis B patients in two late‑stage studies, a result that could shift the disease from lifelong therapy to a finite regimen. Regulators are reviewing the drug...
EClinicalWorks AI-Powered EHR Strengthens Access to Care and Operational Efficiency at Rural Tennessee Clinic
Medical Specialty Clinic in rural Tennessee adopted eClinicalWorks' AI‑powered EHR suite to boost patient access and streamline operations across in‑person, telehealth, and home visits. AI tools such as Sunoh.ai, PRISMA, and healow Genie cut documentation time, while integrated billing and...
Beren Therapeutics Announces FDA Extension of Review Period for New Drug Application (NDA) for Adrabetadex for the Treatment of Infantile-Onset...
Beren Therapeutics announced that the FDA has extended the review period for its New Drug Application for adrabetadex, a cyclodextrin‑based therapy for infantile‑onset Niemann‑Pick disease type C, by three months. The new PDUFA target action date is November 17, 2026, following a major...
AI Meets Olfaction: SpotitEarly Unveils LUCID 2.0, Scaling Early Cancer Detection to Millions
SpotitEarly introduced LUCID 2.0, a bio‑AI hybrid platform that pairs trained detection dogs with a multi‑modal sensor array and deep‑learning algorithms to deliver breath‑based cancer screening at clinical scale. The system can process up to 1.73 million tests per year per center...
Telemedicine Eliminates Provider Silos and Enables Care Coordination
In a HIMSS26 interview, Juli Hysenbelli of the HIMSS Virtual Care Community and ATA CEO Kyle Zebley explain how telemedicine can dissolve traditional provider silos and create a unified view of patient data. They argue that virtual care platforms enable...
Medix Launches Executive Search Practice Focused on Revenue Cycle Leadership
Medix announced a new executive‑search practice dedicated to senior revenue‑cycle leadership roles in healthcare. The service uses a retained, commitment‑based model that prioritizes exclusive, high‑touch engagements. By proactively mapping passive talent, Medix aims to fill critical positions that are hard...